Form 4: Singular Genomics Systems CEO Andrew Spaventa Reports Stock Transactions
SEC Form 4 Filing
CEO Andrew Spaventa reports acquisition and disposal of Singular Genomics Systems (OMIC) stock, including shares from vested Restricted Stock Units (RSUs) and gifts to a living trust.
Summary
- On June 15, 2024, Andrew Spaventa, CEO of Singular Genomics Systems, Inc. (OMIC), reported transactions involving the company's common stock.
- These transactions included the acquisition of 14,584 shares through the settlement of vested Restricted Stock Units (RSUs).
- Spaventa also disposed of 14,584 shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
- Following these transactions, Spaventa directly owns 9,766 shares and indirectly owns 4,162,144 shares through The Andrew K. Spaventa Living Trust and 2,569 shares through Axon Holdings, LLC.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Related Party Transactions
- The gift of shares to The Andrew K. Spaventa Living Trust is a related party transaction.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly altering the ownership structure.
Key Dates
| Date | Description |
|---|---|
| April 9, 2014 | Date of The Andrew K. Spaventa Living Trust |
| March 15, 2023 | RSUs vest in 16 equal quarterly installments over four years measured from this date. |
| June 15, 2024 | Date of stock transactions (acquisition and disposal of shares) |
| June 18, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.